Crawford Investigation Finds "No Evidence" On Three Of Four Personal Conduct Allegations
This article was originally published in The Pink Sheet Daily
Executive Summary
The HHS Inspector General finds no evidence of impropriety by the FDA commissioner nominee on three of four allegations relating to his interactions with an agency subordinate but cites "inconsistencies" concerning a fourth allegation. A Senate Health Committee majority staffer says a vote on Crawford's nomination is likely by August.
You may also be interested in...
Next Round For Commissioner Nominee: Crawford Placed On Hold After Clearing Senate Health Committee
The nomination of Acting Commissioner Crawford to the permanent FDA post passed the committee. A full Senate vote will be delayed by a long-anticipated hold placed by Sens. Murray and Clinton, who demand the agency first make a decision on the OTC switch of Barr's Plan B emergency contraceptive.
Next Round For Commissioner Nominee: Crawford Placed On Hold After Clearing Senate Health Committee
The nomination of Acting Commissioner Crawford to the permanent FDA post passed the committee. A full Senate vote will be delayed by a long-anticipated hold placed by Sens. Murray and Clinton, who demand the agency first make a decision on the OTC switch of Barr's Plan B emergency contraceptive.
Crawford’s FDA Confirmation Woes Grow With Sen. Coburn’s Threatened Hold
The Oklahoma Republican says he will place a hold on FDA Commissioner nominee Crawford because the agency has not finalized condom labeling rules. Coburn joins a list of Democrats who are also threatening to place a hold on Crawford’s nomination.